Our Vision

'We exist to improve patient care and quality of life through imagination, intuition and innovation'

Our Purpose

‘Transforming lives through design intelligence’

BioMimics 3D® Vascular Stent System

The BioMimics 3D Vascular Stent System has a unique 3D helical geometry which imparts a gentle helical shape to the stented artery.

MIMICS-2 3-year data released

Professor Thomas Zeller PI of the MIMICS-2 IDE study has announced that the freedom from CDTLR at 3 years for the BioMimics 3D stent was 81%, which is comparable to the outcomes for DCB, DES and Supera, despite treating more challenging lesions and without the need for lesion preparation.

Veryan & Otsuka

Veryan was founded in 2005 as the result of a technology spin out from Imperial College, London.

The Latest from Veryan

News, updates and insights

LOGO

Clinical Evidence

BioMimics 3D US launch

Veryan Medical (Horsham, UK) today announced that it has launched the innovative BioMimics 3D Vascular Stent System in the US. The BioMimics 3D self-expanding, nitinol stent features a highly-differentiated, helical centre-line design that has achieved excellent clinical outcomes in clinical trials, including a pivotal study with 3-year follow-up.

Joint announcement by Veryan and Walk Vascular

Walk Vascular, LLC (Irvine, CA) and Veryan Medical (Horsham, UK) have announced that Veryan Medical will support Walk Vascular in the commercialization of the innovative JETi Peripheral Thrombectomy System in Germany.

36-month results from Veryan Medical’s MIMICS-2 study at CX 2020 Live

Professor Thomas Zeller (University Heart Centre Freiburg, Bad Krozingen, Germany) today presented the 36-month results from Veryan Medical’s MIMICS-2 study at CX 2020 Live.

Get in touch

Find contact details and send us a message.

Contact us

Veryan Design Intelligence:imagination + intuition + innovation